Drugs / SLV-351
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00581191 | Jan → Mar 2008 | — | Wyeth is now a wholly owned subsidiary of Pfizer | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SLV-351 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00581191 ↗ |
| Route | Oral | “SLV-351 Administered Orally” NCT00581191 ↗ |